Skip to main content

Table 3 Frequency of fractures among ADT users and nonusers by extent of disease

From: Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand

  Any fracture Hip fracture Vertebral fracture
Localised
 No ADT (N = 3638) 63 (1.7 %) 7 (0.2 %) 10 (0.3 %)
 Any ADT (N = 172) 10 (5.8 %) 2 (1.2 %) 2 (1.2 %)
Locally advanced or Metastatic
 No ADT (N = 1404) 71 (5.1 %) 6 (0.4 %) 16 (1.1 %)
 Any ADT (N = 1707) 335 (19.6 %) 43 (2.5 %) 19 (1.1 %)
Unknown
 No ADT (N = 11,125) 390 (3.5 %) 107 (1.0 %) 110 (1.0 %)
 Any ADT (N = 7498) 669 (8.9 %) 173 (2.3 %) 116 (1.6 %)
  1. ADT androgen deprivation therapy